A share price of Oscar Health Inc [OSCR] is currently trading at $18.43, up 6.35%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The OSCR shares have gain 15.33% over the last week, with a monthly amount glided 9.70%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Oscar Health Inc [NYSE: OSCR] stock has seen the most recent analyst activity on November 06, 2024, when BofA Securities downgraded its rating to a Underperform and also revised its price target to $13.50 from $21. Previously, UBS started tracking the stock with Neutral rating on October 07, 2024, and set its price target to $23. On June 26, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $25 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $28 on May 30, 2024. BofA Securities downgraded its rating to a Neutral and reduced its price target to $21 on May 30, 2024. Raymond James started tracking with a Outperform rating for this stock on March 22, 2024, and assigned it a price target of $20. In a note dated November 02, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $8 to $9.
Oscar Health Inc experienced fluctuations in its stock price throughout the past year between $7.29 and $23.79. Currently, Wall Street analysts expect the stock to reach $20.2 within the next 12 months. Oscar Health Inc [NYSE: OSCR] shares were valued at $18.43 at the most recent close of the market. An investor can expect a potential return of 9.6% based on the average OSCR price forecast.
Analyzing the OSCR fundamentals
Trailing Twelve Months sales for Oscar Health Inc [NYSE:OSCR] were 8.22B which represents 68.30% growth. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.0%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is -0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.57 points at the first support level, and at 16.70 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.06, and for the 2nd resistance point, it is at 19.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Oscar Health Inc [NYSE:OSCR] is 0.78. Considering the valuation of this stock, the price to sales ratio is 0.57, the price to book ratio is 3.92.
Transactions by insiders
Recent insider trading involved Alessandrea Quane, EVP, Chief Insurance Officer, that happened on Dec 02 ’24 when 29585.0 shares were purchased. Chief Legal Officer, Ranmali Bopitiya completed a deal on Dec 02 ’24 to buy 21073.0 shares. Meanwhile, Dir, Pres. of Technology & CTO Schlosser Mario bought 7128.0 shares on Dec 02 ’24.